Replies to post #469459 on NorthWest Biotherapeutics Inc (NWBO)

[DavidW2]

Hmm...company is doing everything they can to promote this presentation. Two PRs in a week. Something definitely is going on....if it is repeat data review, there is no point to do this way.

[pgsd]

Really interesting as the website for the slides as mentioned in pr state the following

DCVax®-L is an experimental vaccine therapy for the treatment of brain tumors

(5/10/22) The results of the double blind, randomized, placebo controlled Phase III clinical trial with DCVax-L for newly diagnosed GBM was just released. We will soon post the slide deck of the results as well as the video of the presentation.

[NotSure2]

This PR 100% confirm no TLD release.

No more excuse to not use the words "TLD Release".

If TLD was to be release, they would say it in this PR, which is less than 120 minutes away...

[CogDiss 1188X]

This PR stuff is kind of messed up. NWBO says “Additionally, the slides used in the presentation will be posted online concurrently with or promptly following the presentation at Virtualtrials.org/Dcvax. The slides will not be posted on the Company's website.”

https://www.prnewswire.com/news-releases/presentation-about-phase-3-trial-of-dcvax-l-for-glioblastoma-today-at-new-york-academy-of-sciences-to-be-available-online-as-well-301544019.html

Al Muesella’s foundation website, referenced in the PR, changes it to “the results of the trial was just released:”

The results of the double blind, randomized, placebo controlled Phase III clinical trial with DCVax-L for newly diagnosed GBM was just released. We will soon post the slide deck of the results as well as the video of the presentation.